HSDT
Helius Medical Technologies Inc
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
helius medical technologies, inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. the company's product is portable neuromodulation stimulator (pons), a medical device in canada for the treatment of chronic balance deficit due to mild-to-moderate traumatic brain injury. its pons device treats neurostimulation of cranial nerves via the tongue to restore lost function. the company is headquartered in newtown, pennsylvania.
Market Cap: 4.06 Million
Primary Exchange: NASDAQ
Website: http://www.heliusmedical.com/
Shares Outstanding: 708 Thousand
Float: 0
Dividend: 0.0 (0.0%)
Beta: 1.7773111004537077
Sector: Manufacturing
Industry: Electromedical and Electrotherapeutic Apparatus Manufacturing
Ethical Flags
Longest drawdown: 939 trading days
From: 2021-04-08 To: 2024-03-07
Lowest Point:
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|